<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36558835</PMID><DateRevised><Year>2022</Year><Month>12</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-0817</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>08</Day></PubDate></JournalIssue><Title>Pathogens (Basel, Switzerland)</Title><ISOAbbreviation>Pathogens</ISOAbbreviation></Journal><ArticleTitle>Approximations to Diagnosis and Therapy of COVID-19 in Nervous Systems Using Extracellular Vesicles.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1501</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens11121501</ELocationID><Abstract><AbstractText>The SARS-CoV-2 virus was first identified at the end of December 2019, causing the disease known as COVID-19, which, due to the high degree of contagion, was declared a global pandemic as of 2020. The end of the isolation was in 2022, thanks to the global multidisciplinary work of the massive vaccination campaigns. Even with the current knowledge about this virus and the COVID-19 disease, there are many questions and challenges regarding diagnosis and therapy in the fight against this virus. One of the big problems is the so-called "long COVID", prolonged symptomatology characterized as a multiorgan disorder manifested as brain fog, fatigue, and shortness of breath, which persist chronically after the disease resolution. Therefore, this review proposes using extracellular vesicles (EVs) as a therapeutic or diagnostic option to confront the sequelae of the disease at the central nervous system level. Development: the review of updated knowledge about SARS-CoV-2 and COVID-19 is generally addressed as well as the current classification of extracellular vesicles and their proposed use in therapy and diagnosis. Through an analysis of examples, extracellular vesicles are highlighted to learn what happens in the central nervous system during and after COVID-19 and as a therapeutic option. Conclusions: even though there are limitations in the knowledge of the neurological manifestations of COVID-19, it is possible to observe the potential use of extracellular vesicles in therapy or as a diagnostic method and even the importance of their study for the knowledge of the pathophysiology of the disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Karen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6615-6310</Identifier><AffiliationInfo><Affiliation>Medical and Pharmaceutical Biotechnology Unit, Center for Research and Assistance in Technology and Design of the State of Jalisco, A.C. (CIATEJ), Av. Normalistas 800, Colinas de la Normal, Guadalajara C.P. 44270, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verdugo-Molinares</LastName><ForeName>Maritza G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Medical and Pharmaceutical Biotechnology Unit, Center for Research and Assistance in Technology and Design of the State of Jalisco, A.C. (CIATEJ), Av. Normalistas 800, Colinas de la Normal, Guadalajara C.P. 44270, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ochoa-Ruiz</LastName><ForeName>Andrea G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0001-9873-6144</Identifier><AffiliationInfo><Affiliation>Medical and Pharmaceutical Biotechnology Unit, Center for Research and Assistance in Technology and Design of the State of Jalisco, A.C. (CIATEJ), Av. Normalistas 800, Colinas de la Normal, Guadalajara C.P. 44270, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canales</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0918-788X</Identifier><AffiliationInfo><Affiliation>Medical and Pharmaceutical Biotechnology Unit, Center for Research and Assistance in Technology and Design of the State of Jalisco, A.C. (CIATEJ), Av. Normalistas 800, Colinas de la Normal, Guadalajara C.P. 44270, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reza-Zaldivar</LastName><ForeName>Edwin E</ForeName><Initials>EE</Initials><Identifier Source="ORCID">0000-0001-5702-9515</Identifier><AffiliationInfo><Affiliation>Tecnologico de Monterrey, Institute for Obesity Research, Av. General Ram&#xf3;n Corona 2514, Zapopan C.P. 45201, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim&#xf3;n-Rojas</LastName><ForeName>Areli</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical and Pharmaceutical Biotechnology Unit, Center for Research and Assistance in Technology and Design of the State of Jalisco, A.C. (CIATEJ), Av. Normalistas 800, Colinas de la Normal, Guadalajara C.P. 44270, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallejo-Cardona</LastName><ForeName>Alba Adriana</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-4568-3787</Identifier><AffiliationInfo><Affiliation>Medical and Pharmaceutical Biotechnology Unit, CONACYT-Center for Research and Assistance in Technology and Design of the State of Jalisco, A.C., Av. Normalistas 800, Colinas de la Normal, Guadalajara C.P. 44270, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pathogens</MedlineTA><NlmUniqueID>101596317</NlmUniqueID><ISSNLinking>2076-0817</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">diagnostic</Keyword><Keyword MajorTopicYN="N">extracellular vesicles (EVs)</Keyword><Keyword MajorTopicYN="N">therapy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36558835</ArticleId><ArticleId IdType="pmc">PMC9782638</ArticleId><ArticleId IdType="doi">10.3390/pathogens11121501</ArticleId><ArticleId IdType="pii">pathogens11121501</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soltani S., Tabibzadeh A., Zakeri A., Zakeri A.M., Latifi T., Shabani M., Pouremamali A., Erfani Y., Pakzad I., Malekifar P., et al. COVID-19 associated central nervous system manifestations, mental and neurological symptoms: A systematic review and meta-analysis. Rev. Neurosci. 2021;32:351&#x2013;361. doi: 10.1515/revneuro-2020-0108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2020-0108</ArticleId><ArticleId IdType="pubmed">33618441</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassanpour M., Rezaie J., Nouri M., Panahi Y.Y. The role of extracellular vesicles in COVID-19 virus infection. Infect. Genet. Evol. 2020;85:104422. doi: 10.1016/j.meegid.2020.104422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2020.104422</ArticleId><ArticleId IdType="pmc">PMC7293471</ArticleId><ArticleId IdType="pubmed">32544615</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Laksono B.M., de Vrij F.M.S., Kushner S.A., Harschnitz O., van Riel Y.D. The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2. Trends Neurosci. 2022;45:358&#x2013;368. doi: 10.1016/j.tins.2022.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M.L.C., Lely A.T., Navis G.J., van Goor Y.H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.A., Islam K., Rahman S., Alamin Y.M. Neurobiochemical Cross-talk between COVID-19 and Alzheimer&#x2019;s Disease. Mol. Neurobiol. 2021;58:1017&#x2013;1023. doi: 10.1007/s12035-020-02177-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02177-w</ArticleId><ArticleId IdType="pmc">PMC7571527</ArticleId><ArticleId IdType="pubmed">33078369</ArticleId></ArticleIdList></Reference><Reference><Citation>Abate G., Memo M., Uberti Y.D. Impact of COVID-19 on Alzheimer&#x2019;s Disease Risk: Viewpoint for Research Action. Healthcare. 2020;8:286. doi: 10.3390/healthcare8030286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8030286</ArticleId><ArticleId IdType="pmc">PMC7551579</ArticleId><ArticleId IdType="pubmed">32839380</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R., Soung A., Sissoko C., Nordvig A., Canoll P., Mariani M., Jiang X., Bricker T., Goldman J., Rosoklija G., et al. COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis. Res. Sq. 2022. preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1031824/v1</ArticleId><ArticleId IdType="pmc">PMC9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S., Nath Y.A. Nervous system consequences of COVID-19. Insights. 2022;375:267&#x2013;270. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltr&#xe1;n-Gracia E., L&#xf3;pez-Camacho A., Higuera-Ciapara I., Vel&#xe1;zquez-Fern&#xe1;ndez J.B., Vallejo-Cardona Y.A.A. Nanomedicine review: Clinical developments in liposomal applications. Cancer Nanotechnol. 2019;10:11. doi: 10.1186/s12645-019-0055-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12645-019-0055-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanninen K.M., Bister N., Koistinaho J., Malm Y.T. Exosomes as new diagnostic tools in CNS diseases. Biochim. Et Biophys. Acta (BBA)&#x2014;Mol. Basis Dis. 2016;1862:403&#x2013;410. doi: 10.1016/j.bbadis.2015.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2015.09.020</ArticleId><ArticleId IdType="pubmed">26432482</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez L.E., Sinitsyna S.M.d., Qui&#xf1;ones M.A.d., Dom&#xed;nguez L.V., de M&#xe9;xico Y.M.V.S.C. Infecci&#xf3;n del sistema nervioso por el coronavirus SARS-CoV-2. Rev. Fac. Med. UNAM. 2021;64:7&#x2013;24.</Citation></Reference><Reference><Citation>Carod-Artal F.J. Neurological complications of coronavirus and COVID-19. Rev. Neurol. 2020;70:311&#x2013;322. doi: 10.33588/RN.7009.2020179.</Citation><ArticleIdList><ArticleId IdType="doi">10.33588/RN.7009.2020179</ArticleId><ArticleId IdType="pubmed">32329044</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Liu J., Shi Y.P.-Y. SARS-CoV-2 Variants and Vaccination. Zoonoses. 2022;2:6. doi: 10.15212/ZOONOSES-2022-0001.</Citation><ArticleIdList><ArticleId IdType="doi">10.15212/ZOONOSES-2022-0001</ArticleId><ArticleId IdType="pmc">PMC8909890</ArticleId><ArticleId IdType="pubmed">35284912</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocozza F., Cocozza F., N&#xe9;vo N., Piovesana E., Lahaye X., Buchrieser J., Schwartz O., Manel N., Tkach M., Th&#xe9;ry C., et al. Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus. J. Extracell Vesicles. 2020;10:12050. doi: 10.1002/jev2.12050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12050</ArticleId><ArticleId IdType="pmc">PMC7769856</ArticleId><ArticleId IdType="pubmed">33391636</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergara J.P., Tolosa Y.C. Covid 19: Manifestaciones neurol&#xf3;gicas TT&#x2014;COVID-19: Neurological manifestations. Acta Neurol&#xf3;gica Colomb. 2020;36((Suppl. 1)):7&#x2013;10. doi: 10.22379/24224022288.</Citation><ArticleIdList><ArticleId IdType="doi">10.22379/24224022288</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar J., Makheja K., Rahul F., Kumar S., Kumar M., Chand M., Kammawal Y., Khalid D., Jahangir M., Bachani P. Long-Term Neurological Impact of COVID-19. Cureus. 2021;13:e18131. doi: 10.7759/cureus.18131.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18131</ArticleId><ArticleId IdType="pmc">PMC8528473</ArticleId><ArticleId IdType="pubmed">34692340</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison Y.P.J. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Duque-Parra J.E., Duque-Montoya D., Pel&#xe1;ez Y.F.J.C. El COVID-19 tambi&#xe9;n Afecta el Sistema Nervioso por una de sus Compuertas: El &#xd3;rgano Vascular de la L&#xe1;mina Terminal y el Nervio Olfatorio. Alerta Neurol&#xf3;gica, Prueba de Disosmia o Anosmia Puede Ayudar a Un Diagn&#xf3;stico R&#xe1;pido. Int. J. Odontostomatol. 2020;14:285&#x2013;287. doi: 10.4067/S0718-381X2020000300285.</Citation><ArticleIdList><ArticleId IdType="doi">10.4067/S0718-381X2020000300285</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M., Khaleeq A., Ali U., Syeda Y.H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem. Neurosci. 2020;11:995&#x2013;998. doi: 10.1021/acschemneuro.0c00122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00122</ArticleId><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolen L.T., Mukerji S.S., Mejia Y.N.I. Post-acute neurological consequences of COVID-19: An unequal burden. Nat. Med. 2022;28:20&#x2013;23. doi: 10.1038/s41591-021-01647-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01647-5</ArticleId><ArticleId IdType="pubmed">35039657</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N., Simr&#xe9;n J., Ed&#xe9;n A., Andersson L.-M., Nilsson S., Ashton N.J., Sundvall P.-D., Nellg&#xe5;rd B., Blennow K., Zetterberg H., et al. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. EBioMedicine. 2021;70:103512. doi: 10.1016/j.ebiom.2021.103512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103512</ArticleId><ArticleId IdType="pmc">PMC8320425</ArticleId><ArticleId IdType="pubmed">34333238</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Menacho J., Villas-Roca M., Casta&#xf1;&#xe9; H., Joven J., Camps J., Iftimie Y.S. Can COVID-19 vaccines relieve severe tension-type headache and migraine? Med. Hypotheses. 2022;161:110812. doi: 10.1016/j.mehy.2022.110812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2022.110812</ArticleId><ArticleId IdType="pmc">PMC8863372</ArticleId><ArticleId IdType="pubmed">35221450</ArticleId></ArticleIdList></Reference><Reference><Citation>Min Y.G., Ju W., Ha Y.-E., Ban J.-J., Lee S.A., Sung J.-J., Shin J.-Y. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature. J. Neuroimmunol. 2021;359:577691. doi: 10.1016/j.jneuroim.2021.577691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2021.577691</ArticleId><ArticleId IdType="pmc">PMC8349403</ArticleId><ArticleId IdType="pubmed">34416410</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh J.S., Goh Y., Tan B.Y.-Q., Hui A.C.-F., Hoe R.H.M., Makmur A., Kei P.L., Vijayan J., Ng K.W.P., Quek A.M.L. Neuralgic amyotrophy following COVID-19 mRNA vaccination. QJM Int. J. Med. 2021;114:503&#x2013;505. doi: 10.1093/qjmed/hcab216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab216</ArticleId><ArticleId IdType="pubmed">34347105</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Tamborska A.A., Doheim M.F., Garcia-Azorin D., Gezegen H., Guekht A., Khan A.H.K.Y., Santacatterina M., Sejvar J., Thakur K.T., et al. Neurological Events Reported after COVID-19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System. Ann. Neurol. 2022;91:756&#x2013;771. doi: 10.1002/ana.26339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26339</ArticleId><ArticleId IdType="pmc">PMC9082459</ArticleId><ArticleId IdType="pubmed">35233819</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Lersy F., Anheim M., Merdji H., Schenck M., Oesterl&#xe9; H., Bolognini F., Messie J., Khalil A., Gaudemer A., et al. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study. Neurology. 2020;95:e1868&#x2013;e1882. doi: 10.1212/WNL.0000000000010112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010112</ArticleId><ArticleId IdType="pubmed">32680942</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaimardanova A., Solovyeva V., Chulpanova D., James V., Kitaeva K., Rizvanov Y.A. Extracellular vesicles in the diagnosis and treatment of central nervous system diseases. Neural Regen Res. 2020;15:586. doi: 10.4103/1673-5374.266908.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.266908</ArticleId><ArticleId IdType="pmc">PMC6975137</ArticleId><ArticleId IdType="pubmed">31638080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlotnik Y., Gadoth A., Abu-Salameh I., Horev A., Novoa R., Ifergane Y.G. Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination. Front Immunol. 2022;12:5749. doi: 10.3389/fimmu.2021.813487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.813487</ArticleId><ArticleId IdType="pmc">PMC8766789</ArticleId><ArticleId IdType="pubmed">35069602</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B., Tang N., Peluso M.J., Iyer N.S., Torres L., Donatelli J.L., Munter S.E., Nixon C.C., Rutishauser R.L., Rodriguez-Barraquer I., et al. Characterization and biomarker analyses of post-covid-19 complications and neurological manifestations. Cells. 2021;10:386. doi: 10.3390/cells10020386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafiane A., Daskalopoulou Y.S.S. Extracellular vesicles characteristics and emerging roles in atherosclerotic cardiovascular disease. Metabolism. 2018;85:213&#x2013;222. doi: 10.1016/j.metabol.2018.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2018.04.008</ArticleId><ArticleId IdType="pubmed">29727628</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo M., Raposo G., Th&#xe9;ry Y.C. Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles. Annu. Rev. Cell Dev. Biol. 2014;30:255&#x2013;289. doi: 10.1146/annurev-cellbio-101512-122326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-101512-122326</ArticleId><ArticleId IdType="pubmed">25288114</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J., Li J., Huang B., Liu J., Chen X., Chen X.-M., Xu Y.-M., Huang L.-F., Wang X.-Z. Exosomes: Novel Biomarkers for Clinical Diagnosis. Sci. World J. 2015;2015:657086. doi: 10.1155/2015/657086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/657086</ArticleId><ArticleId IdType="pmc">PMC4322857</ArticleId><ArticleId IdType="pubmed">25695100</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming A., Sampey G., Chung M.-C., Bailey C., van Hoek M.L., Kashanchi F., Hakami R.M. The carrying pigeons of the cell: Exosomes and their role in infectious diseases caused by human pathogens. Pathog. Dis. 2014;71:109&#x2013;120. doi: 10.1111/2049-632X.12135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2049-632X.12135</ArticleId><ArticleId IdType="pubmed">24449527</ArticleId></ArticleIdList></Reference><Reference><Citation>Su H., Rustam Y.H., Masters C.L., Makalic E., McLean C.A., Hill A.F., Barnham K.J., Reid G.E., Vella L.J. Characterization of brain-derived extracellular vesicle lipids in Alzheimer&#x2019;s disease. J. Extracell Vesicles. 2021;10:12089. doi: 10.1002/jev2.12089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12089</ArticleId><ArticleId IdType="pmc">PMC8111496</ArticleId><ArticleId IdType="pubmed">34012516</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacchi E., Burrello J., Di Silvestre D., Burrello A., Bolis S., Mauri P., Vassalli G., Cereda C.W., Farina C., Barile L., et al. Immune profiling of plasma-derived extracellular vesicles identifies Parkinson disease. Neurol. Neuroimmunol. Neuroinflamm. 2020;7:e866. doi: 10.1212/NXI.0000000000000866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000866</ArticleId><ArticleId IdType="pmc">PMC7428368</ArticleId><ArticleId IdType="pubmed">32817412</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Xu R., Rai A., Suwakulsiri W., Izumikawa K., Ishikawa H., Greening D., Takahashi N., Simpson R.J. Distinct shed microvesicle and exosome microRNA signatures reveal diagnostic markers for colorectal cancer. PLoS ONE. 2019;14:e0210003. doi: 10.1371/journal.pone.0210003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0210003</ArticleId><ArticleId IdType="pmc">PMC6319712</ArticleId><ArticleId IdType="pubmed">30608951</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannerstr&#xf6;m B., Kornilov R., Abu-Shahba A.G., Chowdhury I.M., Sinha S., Sepp&#xe4;nen-Kaijansinkko R., Kaur S. Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles. Epigenetics. 2019;14:352&#x2013;364. doi: 10.1080/15592294.2019.1585177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15592294.2019.1585177</ArticleId><ArticleId IdType="pmc">PMC6557543</ArticleId><ArticleId IdType="pubmed">30907225</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo T., Figueroa-Romero C., Hur J., Pacut C., Stoll E., Spring C., Lewis R., Nair A., Goutman S.A., Sakowski S.A., et al. Extracellular Vesicles in Serum and Central Nervous System Tissues Contain microRNA Signatures in Sporadic Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2021;14:739016. doi: 10.3389/fnmol.2021.739016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.739016</ArticleId><ArticleId IdType="pmc">PMC8586523</ArticleId><ArticleId IdType="pubmed">34776863</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Morales R., Ripa I., L&#xf3;pez-Guerrero Y.J.A. Extracellular vesicles in viral spread and antiviral response. Viruses. 2020;12:623. doi: 10.3390/v12060623.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12060623</ArticleId><ArticleId IdType="pmc">PMC7354624</ArticleId><ArticleId IdType="pubmed">32521696</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues M., Fan J., Lyon C., Wan M., Hu Y.Y. Role of extracellular vesicles in viral and bacterial infections: Pathogenesis, diagnostics, and therapeutics. Theranostics. 2018;8:2709&#x2013;2721. doi: 10.7150/thno.20576.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.20576</ArticleId><ArticleId IdType="pmc">PMC5957004</ArticleId><ArticleId IdType="pubmed">29774070</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill A.F. Extracellular Vesicles and Neurodegenerative Diseases. J. Neurosci. 2019;39:9269&#x2013;9273. doi: 10.1523/JNEUROSCI.0147-18.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0147-18.2019</ArticleId><ArticleId IdType="pmc">PMC6867808</ArticleId><ArticleId IdType="pubmed">31748282</ArticleId></ArticleIdList></Reference><Reference><Citation>Rufino-Ramos D., Albuquerque P.R., Carmona V., Perfeito R., Nobre R.J., de Almeida Y.L.P. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases. J. Control. Release. 2017;262:247&#x2013;258. doi: 10.1016/j.jconrel.2017.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2017.07.001</ArticleId><ArticleId IdType="pubmed">28687495</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascellino M.T., Di F., Massimiliano T., Angelis D., Oliva Y.A. Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action. Effic. Saf. 2021;ume 14:3459&#x2013;3476. doi: 10.2147/IDR.S315727.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S315727</ArticleId><ArticleId IdType="pmc">PMC8418359</ArticleId><ArticleId IdType="pubmed">34511939</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal S., Perincheri S., Fleming T., Poulson C., Tiffany B., Bremner R.M., Mohanakumar T. Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer&#x2013;BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines. J. Immunol. 2021;207:2405&#x2013;2410. doi: 10.4049/jimmunol.2100637.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100637</ArticleId><ArticleId IdType="pmc">PMC11073804</ArticleId><ArticleId IdType="pubmed">34654691</ArticleId></ArticleIdList></Reference><Reference><Citation>Aryani A., Denecke Y.B. Exosomes as a Nanodelivery System: A Key to the Future of Neuromedicine? Mol. Neurobiol. 2014;53:818&#x2013;834. doi: 10.1007/s12035-014-9054-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-9054-5</ArticleId><ArticleId IdType="pmc">PMC4752585</ArticleId><ArticleId IdType="pubmed">25502465</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Shennawy L., Hoffmann A.D., Dashzeveg N.K., McAndrews K.M., Mehl P.J., Cornish D., Yu Z., Tokars V.L., Nicolaescu V., Tomatsidou A., et al. Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2. Nat. Commun. 2022;13:405. doi: 10.1038/s41467-021-27893-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27893-2</ArticleId><ArticleId IdType="pmc">PMC8776790</ArticleId><ArticleId IdType="pubmed">35058437</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam S.M., Huang X., Shui Y.G. Neurological aspects of SARS-CoV-2 infection: Lipoproteins and exosomes as Trojan horses. Trends Endocrinol. Metab. 2022;33:554&#x2013;568. doi: 10.1016/j.tem.2022.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2022.04.011</ArticleId><ArticleId IdType="pmc">PMC9058057</ArticleId><ArticleId IdType="pubmed">35613979</ArticleId></ArticleIdList></Reference><Reference><Citation>Karn V., Ahmed S., Tsai L.-W., Dubey R., Ojha S., Singh H.N., Kumar M., Gupta P.K., Sadhu S., Jha N.K., et al. Extracellular vesicle-based therapy for COVID-19: Promises, challenges and future prospects. Biomedicines. 2021;9:1373. doi: 10.3390/biomedicines9101373.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9101373</ArticleId><ArticleId IdType="pmc">PMC8533559</ArticleId><ArticleId IdType="pubmed">34680490</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta V., Sengupta S., Lazo A., Woods P., Nolan A., Bremer Y.N. Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19. Stem Cells Dev. 2020;29:747&#x2013;754. doi: 10.1089/scd.2020.0080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2020.0080</ArticleId><ArticleId IdType="pmc">PMC7310206</ArticleId><ArticleId IdType="pubmed">32380908</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadique M.A., Yadav S., Ranjan P., Khan R., Khan F., Kumar A., Biswas D. Highly Sensitive Electrochemical Immunosensor Platforms for Dual Detection of SARS-CoV-2 Antigen and Antibody based on Gold Nanoparticle Functionalized Graphene Oxide Nanocomposites. ACS Appl. Bio. Mater. 2022;5:2421&#x2013;2430. doi: 10.1021/acsabm.2c00301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsabm.2c00301</ArticleId><ArticleId IdType="pubmed">35522141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>